Availability of treatment for eclampsia in public health institutions in Maharashtra, India

Journal of Health, Population and Nutrition

Volumn 31, Issue 1, 2013, Pages 86-95

  Chaturvedi, Sarika ^a   Randive, Bharat ^a   Mistry, Nerges ^a  

^a Foundation for Research in Community Health India   (India)

Author keywords

Anticonvulsant eclampsia; Eclampsia epidemiology; Eclampsia therapy; India; Magnesium sulphate; Pregnancy complication; Public health system

Indexed keywords

EID: 84875773199     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: 10.3329/jhpn.v31i1.14753     Document Type: Article

References (31)

1. World Health Organization. World health statistics 2012. Part 1. Health-related Millennium Development Goals. Geneva: World Health Organization, 2012. 176 p.
2. Singh S, Remez L, Ram U, Moore AM, Audam S. Barriers to safe motherhood in India. New York, NY: Guttmacher Institute, 2009. 33 p.
3. World Health Organization. The World Health Report 2005: make every mother and child count. Geneva: World Health Organization, 2005. 219 p.
4. EngenderHealth. Balancing the scales: expanding treatment for pregnant women with life-threatening hypertensive conditions in developing countries; a report on barriers and solutions to treat pre-eclampsia & eclampsia. New York, NY: EngenderHealth, 2007. 15 p.
5. South African Magpie Trial Collaborators Group. The Magpie study-clinical implications for poor countries. S Afr Med J 2003;93:264-5.
6. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-63.
7. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J et al. Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.
8. Duley L, Gülmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003;(2):CD000025.
9. Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2003;(4):CD000128.
10. Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2003;(4):CD000127.
11. Sheth SS, Chalmers I. Magnesium for preventing and treating eclampsia: time for international action. Lancet 2002;359:1872-3.
12. Aaserud M, Lewin S, Innvaer S, Paulsen EJ, Dahlgren AT, Trommald M et al. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res 2005;5:68.
13. World Health Organization. WHO model list of essential medicines. 15th list. Geneva: World Health Organization, 2007. 27 p. (http://whqlibdoc.who.int/hq/2007/a95075_eng.pdf, accessed on 21 December 2010).
14. World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. Geneva: World Health Organization, 2003. 393 p. (WHO/RHR/00.7).
15. India. Registrar General of India. Special bulletin on maternal mortality in India 2007-09: sample registration system. New Delhi: Office of Registrar General, Ministry of Home Affairs, Government of India, 2011. 4 p.
16. India. Registrar General of India. Maternal mortality in India, 1997-2003: trends, causes and risk factors; sample registration system. New Delhi: Registrar General of India, Government of India, 2006. 29 p.
17. India. National list of essential medicines 2003. New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, 2003. 40 p.
18. India. Government of Maharashtra. Fourth common review mission-Maharashtra 2010. Mumbai: Government of Maharashtra, 2010. 41 p.
19. India. Gendering human development indices: recasting the gender development index and gender empowerment measure for India; summary report. New Delhi: Ministry of Women and Child Development, Government of India, 2009. 16 p.
20. India. Government of Maharashtra. Human development report-Maharashtra 2002. Mumbai: Government of Maharashtra, 2002. 295 p.
21. World Health Organization. Monitoring emergency obstetric care: a handbook. Geneva: World Health Organization, 2009. 152 p.
22. India. Indian Public Health Standard (IPHS) for Community Health Centres: (Revised 2010). New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, 2010. 120 p.
23. India. Guidelines for pregnancy care and management of common obstetric complications by medical officers. New Delhi: Maternal Health Division, Department of Family Welfare, Ministry of Health Family Welfare, Government of India, 2005. 168 p.
24. Sontakke P, Reshmi RS, Sebastian D. Obstetric morbidity among currently married women in selected states of India. J Fam Welf 2009;55:17-26.
25. Luo ZC, An N, Xu HR, Larante A, Audibert F, Fraser WD. The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review. Paediatr Perinat Epidemiol 2007;21(Suppl 1):36-45.
26. Safe Motherhood. Introducing magnesium sulphate for the management of pregnancy induced hypertension. Nairobi: The Safe Motherhood Demonstration Project--Kenya, Ministry of Health, 2005. 2 p. (Safe Motherhood Policy Alert).
27. Veena R, Revikumar KG, Manna PK, Mohanta GP. Emerging trends in medicine procurement in government sector in India-a critical study. Int J Res Pharm Sci 2010;1:372-81.
28. India. Government of Maharashtra. Public Health Department. National Health Programmes. Section 1. Survey design & methodology. Mumbai: Directorate of Health Services, Public Health Department, Government of Maharashtra, 2010. (http://www. maha-arogya.gov.in/programs/nhp/nrhm/facility/ Aurangabad/%20pachod.htm, accessed on 21 December 2010).
29. World Health Organization. Medicines: WHO model list of essential medicines-explanatory notes. Geneva: World Health Organization. (http://www.who.int/medicines/publications/essentialmedicines/en/index.html, accessed on 21 October 2012).
30. George A. Persistence of high maternal mortality in Koppal district, Karnataka, India: observed service delivery constraints. Reprod Health Matters 2007;15:91- 102.
31. MacGillivray I, McCaw-Binns AM, Ashley DE, Fedrick A, Golding J. Strategies to prevent eclampsia in a developing country: II. Use of a maternal pictorial card. Int J Gynaecol Obstet 2004;87:295-300.